BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...
New York’s Commercial Division Rule 25-a, effective November 2025, promotes the use of the Virtual Evidence Courtroom (VEC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results